Orally Administered Salacia reticulata Extract Reduces H1N1 Influenza Clinical Symptoms in Murine Lung Tissues Putatively Due to Enhanced Natural Killer Cell Activity by Gustavo A. Romero-Pérez et al.
March 2016 | Volume 7 | Article 1151
Original research
published: 31 March 2016
doi: 10.3389/fimmu.2016.00115
Frontiers in Immunology | www.frontiersin.org
Edited by: 
Laurel L. Lenz, 
University of Colorado School of 
Medicine, USA
Reviewed by: 
Diego A. Vargas-Inchaustegui, 




Ryo Inoue  
r-inoue@kpu.ac.jp
Specialty section: 
This article was submitted to 
Microbial Immunology, 







Harada Y, Tsuruta T, Oda Y, Ueda F, 
Tsukahara T, Tsukamoto Y and 
Inoue R (2016) Orally Administered 
Salacia reticulata Extract Reduces 
H1N1 Influenza Clinical Symptoms in 
Murine Lung Tissues Putatively Due 
to Enhanced Natural Killer 
Cell Activity. 
Front. Immunol. 7:115. 
doi: 10.3389/fimmu.2016.00115
Orally administered Salacia 
reticulata extract reduces h1n1 
influenza clinical symptoms in 
Murine lung Tissues Putatively  
Due to enhanced natural Killer 
cell activity
Gustavo A. Romero-Pérez1 , Masayo Egashira2 , Yuri Harada2 , Takeshi Tsuruta2 , Yuriko Oda3 , 
Fumitaka Ueda3 , Takamitsu Tsukahara1,2 , Yasuhiro Tsukamoto4 and Ryo Inoue2*
1 Kyoto Institute of Nutrition and Pathology, Kyoto, Japan, 2 Laboratory of Animal Science, Department of Agricultural and 
Life Sciences, Kyoto Prefectural University, Kyoto, Japan, 3 Life Science Research Laboratories, Research and Development 
Management Headquarters, Fujifilm Corporation, Kanagawa, Japan, 4 Laboratory of Animal Hygiene, Department of 
Agricultural and Life Sciences, Kyoto Prefectural University, Kyoto, Japan
Influenza is a major cause of respiratory tract infection. Although most cases do not 
require further hospitalization, influenza periodically causes epidemics in humans that 
can potentially infect and kill millions of people. To countermeasure this threat, new 
vaccines need to be developed annually to match emerging influenza viral strains with 
increased resistance to existing vaccines. Thus, there is a need for finding and devel-
oping new anti-influenza viral agents as alternatives to current treatments. Here, we 
tested the antiviral effects of an extract from the stems and roots of Salacia reticulata 
(SSRE), a plant rich in phytochemicals, such as salacinol, kotalanol, and catechins, 
on H1N1 influenza virus-infected mice. Following oral administration of 0.6 mg/day of 
SSRE, the incidence of coughing decreased in 80% of mice, and only one case of 
severe pulmonary inflammation was detected. Moreover, when compared with mice 
given Lactobacillus casei JCM1134, a strain previously shown to help increase in vitro 
natural killer (NK) cell activity, SSRE-administered mice showed greater and equal NK cell 
activity in splenocytes and pulmonary cells, respectively, at high effector cell:target cell 
ratios. Next, to test whether or not SSRE would exert protective effects against influenza 
in the absence of gut microbiota, mice were given antibiotics before being inoculated 
influenza virus and subsequently administered SSRE. SSRE administration induced an 
increase in NK cell activity in splenocytes and pulmonary cells at levels similar to those 
detected in mice not treated with antibiotics. Based on our results, it can be concluded 
that phytochemicals in the SSRE exerted protective effects against influenza infection 
putatively via modulation of the immune response, including enhancement of NK cell 
activity, although some protective effects were not necessarily through modulation of gut 
microbiota. Further investigation is necessary to elucidate the molecular mechanisms 
underlying the protective effects of SSRE against influenza infection.
Keywords: Salacia reticulata extract, h1n1 influenza virus, Lactobacillus casei JcM1134, antibiotics, gut 
microbiota, natural killer cells, splenocytes, pulmonary cells
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inTrODUcTiOn
Influenza is a leading cause of respiratory tract infection (1). 
Influenza viruses are categorized as A, B, and C (2), and influenza 
A virus can be further subtyped as H3N2, H2N2, and H1N1. 
Every year, approximately 10% of the world’s population is 
infected with influenza (3) that results in 250,000–500,000 deaths 
(4), but in most cases, the infection only lasts for 1–2  weeks 
without the need for hospitalization (4). Nonetheless, influenza 
viruses periodically cause epidemics in humans, such as the 2009 
H1N1 pandemic in Mexico (5), which can potentially infect and 
kill millions of people. Thus, medication with antiviral agents 
that trigger an immune response and inhibit viral replication in 
infected patients is required to prevent further viral spread and 
higher mortality rates among the population.
Following an influenza viral infection, natural killer (NK) cells 
are reportedly activated by proinflammatory cytokines, such as 
interleukin-12 (6) and/or type I interferons (7), and cytotoxicity 
of NK cells is stimulated by interferon-gamma (IFN-γ) (8, 9). 
Since toxicity receptors NKp46 and NKp44 on human NK cells 
readily identify hemagglutinin and neuraminidase on the surface 
of influenza virus, NK cells alone have the potential of destroying 
infected cells (9). Nonetheless, impaired cytotoxicity and deple-
tion of NK cells that lead to higher morbidity and mortality rates 
are often observed in influenza virus-infected subjects for reasons 
not yet fully understood (10). Hence, presently influenza viral 
infections are most efficiently prevented and controlled by vac-
cines that are mainly designed to mobilize a strain-specific anti-
body response to viral surface hemagglutinin or neuraminidase 
(2). Nevertheless, every year, new vaccines need to be developed to 
match emerging influenza viral strains with increased resistance 
to existing vaccines (11, 12). This challenge highlights the need 
for finding and developing new antiviral agents as alternatives to 
those currently available.
Although the human gut microflora is remarkably stable 
under dietary changes (13) and its composition is highly indi-
vidualized (14), administration of lactic acid bacterial (LAB) 
strains, such as those found in fermented food products (15–17), 
has been shown to protect experimental models against influenza 
viral infections by enhancing the immune response (16–20). 
For example, continual consumption of a milk-based drink 
containing a Lactobacillus brevis strain was reported to lower the 
incidence of influenza in unvaccinated schoolchildren in Japan 
(15). These findings emphasize the potential of probiotics as 
complement to conventional vaccine-based approaches for treat-
ment of influenza infection (21). Nonetheless, inconsistency in 
the survival rate of strains (22, 23) and lack of consensus on the 
effective doses (24, 25) are issues needed to be addressed before 
LAB can be considered reliable as therapeutic agents against viral 
infections.
A new generation of antiviral extracts from biological sources 
has shown promising effects against influenza virus. For example, 
Ladania067 from the leaves of black currant (Ribes nigrum folium) 
showed potent antiviral activity against influenza A/Regensburg/
D6/09 (H1N1) (26), although efficacy observed 24 h after intra-
nasal application in  vivo was not higher than 85%. Likewise, a 
crude extract from Crytoporus volvatus, a polypore fungus, showed 
strong activity against H1N1/09 influenza viral infection in mice. 
Nonetheless, while C. volvatus extract indeed reduced virus loads in 
lungs and protected from a lethal viral dose, it failed to substantially 
decrease the virus titer (27). Although Salacia species have long 
been used as therapeutic agents in traditional medicine in Asia for 
treating disorders, such as diabetes, cancer, and immunosuppres-
sion (28, 29), the properties of Salacia species against viral infec-
tions have not been well characterized. Recently, in our premises, 
we observed that an extract from the bark and roots of Salacia 
reticulata induced an increase in activity of immune-related genes, 
including Cd26, IgG2a, TNF-α, and Ccl5 in intestinal epithelial cells 
(IEC) of Sprague-Dawley rats (30). Cd26 and IgG2a are involved in 
cell-mediated immunity (31) and the humoral immune response 
(32), and TNF-α and Ccl5 in the antiviral defense response (33), 
respectively, upon a challenge with influenza virus. Thus, it is likely 
that extracts from S.  reticulata may induce a similar increase in 
immune cell activity after influenza virus infection.
In the present study, we first evaluated the effect of adminis-
tration of an S. reticulata stem and root extract (SSRE) on lung 
damage caused by influenza viral infection. Next, we measured 
NK cell activity in spleen and lungs of influenza virus-infected 
mice to further assay the protective effect of administration of 
SSRE against influenza viral infection, and compared this effect 
with that exerted by a commercially available LAB strain. We 
also investigated the effect of SSRE on NK cell activity in spleen 
and lung cells of mice given a powerful antibiotic cocktail and 
inoculated with H1N1 influenza virus.
MaTerials anD MeThODs
animals
Six-week-old ddY mice were purchased from Japan SLC 
(Shizuoka, Japan) and bred in a pathogen-free animal facility. 
Mice had ad libitum access to regular rodent chow (Lab MR stock; 
Nihon Nosan Kogyo, Tokyo, Japan) and water. Prior to experi-
ments, all mice were allowed to acclimatize for 7 days. The experi-
mental animals were handled in accordance with the guidelines 
for animal studies issued by the Experimental Animal Committee 
of Kyoto Prefectural University (Approval No. KPU270406).
Bacterial and Viral strains
Lactobacillus casei JCM1134 was purchased from Japan 
Collection of Microorganisms (Tsukuba, Japan). L. casei was 
grown under anaerobic conditions at 37°C overnight in 10-mL 
Hungate tubes, with de Man, Rogosa, and Sharpe (MRS) broth 
as medium.
A murine influenza virus, A/PR/8/34/2009 (H1N1), was used 
for this study. Madin–Darby canine kidney cells were infected 
with the virus and after several passages, viral solutions were pre-
pared and titrated as the tissue-culture-infective dose (TCID50), 
according to a standard procedure (34, 35).
Preparation of the hot Water extract of 
S. reticulata
The stems and roots of S. reticulata grown in and imported 
from Sri Lanka were dehydrated and pulverized. The powdered 
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material was boiled in water at 90°C for an hour. The concoction 
was then filtered to remove any solid material, and the result-
ing filtrate was spray-dried (ADL-310, Yamato Science, Tokyo, 
Japan). The SSRE was stored at 4°C until further use.
experimental Design
Experiment 1
Twelve mice were equally divided and allocated to two experi-
mental groups. Mice were orally administrated treatments as 
follows.
 (1) Control group treatment: 500  μL of phosphate-buffered 
saline (PBS; 137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 
and 1.8 mM KH2PO4; pH 7.4).
 (2) SSRE group treatment: 500 μL of SSRE solution (1.2 mg of 
SSRE/mL of PBS).
Experiment 2
Eighteen mice were equally divided and allocated to three 
experimental groups. Mice were orally administrated treatments 
as follows.
 (1) Control group treatment,
 (2) SSRE group treatment,
 (3) Probiotic group treatment: 108 cfu of JCM1134 in 500 μL of 
PBS.
Experiment 3
Eighteen mice were equally divided and allocated to three 
experimental groups. Mice were orally administrated treatments 
as follows.
 (1) Antibiotic–control group (baseline group) treatment: 
antibiotics in drinking water [1 g/L of ampicillin (Nacalai 
Tesque, Kyoto, Japan), 500  mg/L of vancomycin (Wako 
Pure Chemicals, Osaka, Japan), 1  g/L neomycin sulfate 
(Sigma-Aldrich, Tokyo, Japan), and 1  g/L of metroni-
dazole (Nacalai Tesque, Kyoto, Japan)] +  control group 
treatment.
 (2) Antibiotic–SSRE group treatment: antibiotics + SSRE.
 (3) Normal microbiota group treatment: control group 
treatment.
In Experiment 3, administration of antibiotics started 3 days 
prior to administration of SSRE. Treatments in all experiments 
were administered once a day for 2 weeks. The humane endpoint 
was established at a body weight loss >20%, at which mice would 
be killed, as previously suggested (36).
experimental influenza Viral infection  
to Mice
After completion of the treatment period, mice from all 
experiments were intranasally inoculated with 105 TCID50 of 
A/PR/8/34/2009 (H1N1) virus. Five days post-inoculation, 
mice were killed with an overdose of sodium pentobarbital 
(Schering-Plough, K.K. Osaka, Japan). Except for tissues from 
Experiment 1, which were immersed immediately after removal 
in 10% neutral-buffered formalin and used for histopathology 
analysis, all murine lungs and spleen tissues of mice were col-
lected and immediately used for further analyses.
histopathology
Lung tissues of mice from Experiment 1 were used for this experi-
ment. Lung tissues were embedded in paraffin, and 5-μm sections 
were excised from bilateral posterior lobes and stained with 
hematoxylin and eosin (H&E). All samples were randomly num-
bered and examined by an experienced pathologist blinded to the 
study conditions. The pathologist used an Olympus microscope 
(Olympus Optical Co., Ltd., Tokyo, Japan) with a 100× magnifica-
tion lens and scanned the entire surface area of each lung section.
isolation of splenocytes and  
Pulmonary cells
Lung and spleen tissues were sectioned into small pieces and 
immersed in ice-cold Hanks buffered solution (HBSS, Nacalai 
Tesque, Kyoto, Japan). The pieces were gently pressed against ster-
ile 70-μm cell strainers (BD Biosciences Japan, Tokyo, Japan) to 
obtain single-cell suspensions, which were centrifuged at 500 × g 
for 4 min at 4°C. The cell supernatant was retrieved, resuspended 
in ACK lysis buffer (0.5 mol/L of NH4Cl, 10 mmol/L of KHCO3, 
and 0.1  nmol/L of Na2EDTA; pH 7.2), and incubated at room 
temperature for 5  min to remove erythrocytes. The remaining 
cells were washed twice with HBSS and resuspended in 1 mL of 
culture medium [RPMI medium (Nacalai Tesque) containing 
10% fetal bovine serum (FBS), penicillin (100  U/mL, Sigma-
Aldrich Japan, Tokyo, Japan), and streptomycin (100  μg/mL; 
Sigma-Aldrich, Japan)]. Splenocytes and pulmonary cells were 
stained with trypan blue and counted with a TC10 automated cell 
counter (Bio-Rad, Richmond, CA, USA).
nK activity of splenocytes and  
Pulmonary cells
A murine T cell lymphoma cell line, YAC-1, was obtained from 
RIKEN Bio-Resource Center (Ibaraki, Japan). YAC-1 cells were 
cultured in 75-cm2 culture flasks containing 10  mL of culture 
media and incubated in a humidified chamber (37°C, 5% CO2). 
After 3-day incubation, YAC-1 cells were stained for 15 min at 
37°C with 10-μM Dioc18 [3,3′-dioctadecyloxacarbocyanine per-
chlorate (Life Technologies Japan, Tokyo, Japan)] to cause green 
fluorescence of cell membranes. YAC-1 cells were then washed 
twice with 1-mL HBSS and seeded in 100 μL of culture media 
in 96-well culture plates (Orange Scientific, Tokyo, Japan) in a 
concentration of 1.0 × 104 cells (for coculture with splenocytes) 
or 5.0 × 103 cells (for coculture with pulmonary cells) per well.
Natural killer cell activity was assessed by a flow-cytometric 
method, as previously described (37, 38). For the NK activity 
assays, YAC-1 cells were used as target cells, and splenocytes 
and pulmonary cells as effector cells. One hundred microliters 
each of splenocyte and pulmonary cell suspensions were added 
to each well containing DioC18-labeled YAC-1 cells to achieve 
25:1 and 10:1, and 10:1 and 5:1 effector cell:target cell (E:T) 
FigUre 1 | representative images of flow-cytometric analysis for the determination of nK activity. To discriminate the target cells, live gate (red line) was 
set in the FL1 histogram on the green fluorescent (a,B). The target cells were further analyzed with a dot plot of FL1 and FL3 (c–e). Spontaneous lysis of YAC-1 
cells during the incubation was determined for DioC18-labeled YAC-1 cells incubated in the absence of effector cells (c). The gate for the discrimination of live and 
dead target cells (red dotted line) was set in accordance with the red fluorescence of DioC18-labled YAC-1 cells treated with 3% saponin (D). The target cells lysed 
by effector cells appear in the gate for dead cells (e).
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ratios, respectively. After incubation for 4 h, 10 μL of ethidium 
monoazide bromide (EMA, 0.5  ng/mL, Sigma-Aldrich, Japan) 
solution was added to each well for nuclear staining of dead 
cells. The ethidium was bound to nuclei by photo affinity using 
a 26-W fluorescent light (5  cm distance) for 10  min at room 
temperature. After washing twice with PBS containing 0.5% BSA 
(Nacalai Tesque), the cells were fixed with 2% PFA overnight. 
Each sample was incubated in duplicate and analyzed using an 
Accuri C6 flow cytometer (Beckton Dickinson). During the 
data acquisition, a live gate was set in the FL1 histogram on the 
green fluorescent target cells to discriminate effector and target 
cells (Figures 1A,B). At least 2,000 target cells per sample were 
collected. The gated target cells were further analyzed with a dot 
plot of FL1 (green fluorescence) versus FL3 (red fluorescence) to 
calculate the percentage of EMA-positive dead cells.
The percentage of spontaneously lysed target cells was deter-
mined for DioC18-labeled YAC-1 cells incubated for 4 h in the 
absence of effector cells (Figure 1C), and the value was subtracted 
from the data of each sample. Spontaneous lysis of target cells 
ranged from 3 to 10% depending on the experiment. DioC18-
labeled YAC-1 cells treated with 3% saponin were also stained 
with EMA and further analyzed to set the gate for discrimination 
of live and dead cells (Figure 1D). A representative dot plot image 
of the target cells after incubation with effector cells is shown in 
Figure 1E.
statistical analysis
Data of NK activity were analyzed by one-way ANOVA followed 
by Tukey HSD post hoc test to determine significant differences 
among the treatment groups. In all statistical analyses, differences 
were considered significant if P values were <0.05. All data were 
analyzed using freely available R software version 3.1.2 (https://
www.r-project.org/).
resUlTs
effect of Salacia extract
Five days post-infection, mice infected with influenza virus showed 
noticeable clinical symptoms, including sneezing and coughing. 
Nonetheless, upon oral administration of 0.6  mg/day of SSRE, 
80% of mice showed a decrease in the incidence of coughing 
(Table 1).
histopathology
Histopathologically, pulmonary tissues of control mice showed 
typical acute influenza-associated pneumonia, as neutrophilic 
and lymphocyte infiltration was prominent in the alveoli and 
peri-bronchi (Figure 2A). Edema and cell debris were also noted. 
In contrast, pulmonary inflammation was clearly inhibited in 
mice in the SSRE group (Figure  2B), and the influenza cases 
in this group decreased from five severe to one severe and four 
moderate (Table 1).
nK cell activity assays
Comparison between the Effects of Salacia Extract 
and Lactic Acid Bacteria Preparation
At the E:T ratio of 25:1, NK cell activity in splenocytes of SSRE-
administered mice was significantly higher than that observed 
in splenocytes of mice given JCM1134 or in the control group 
FigUre 3 | natural killer cell activity in splenocytes of influenza-
infected mice administered either L. casei JcM1134 or S. reticulata 
stem and root extract. (a) NK cell activity in splenocytes of mice at an 
effector cell:target cell (E:T) ratio of 25:1. (B) NK cell activity in splenocytes of 
mice at an E:T ratio of 10:1. Control: mice given 500 μL of phosphate-
buffered saline (PBS). JCM1134: mice administered 108 cfu of L. casei 
JCM1134 in 500 μL of PBS. SSRE: mice administered 500 μL of S. reticulata 
stem and root extract in PBS (1.2 mg/mL of PBS). Each horizontal bar 
represents the mean value for six mice. *P < 0.05.
FigUre 2 | Pulmonary histopathology of influenza virus-infected mice. Influenza virus-infected mice were administered an S. reticulata stem and root extract 
(SSRE), and their lung tissues were examined histopathologically 5 days post-viral infection. (a) Control group: pulmonary tissue sections from control mice show 
acute influenza pneumonia. In addition, infiltration of inflammatory cells, such as neutrophils and macrophages, can be observed in the alveoli, along with associated 
edema and cell debris. (B) SSRE group: only slight inflammation was observed in the pulmonary tissue sections of SSRE-administered mice.
TaBle 1 | effect of Salacia stem and root extract on influenza virus-infected mice.
Treatment concentration (mg/day) infected mice Viral dose (TciD50) number of mice
symptoms Pulmonary inflammation
sneezing coughing normal Moderate severe
Control 0 5 105 1 5 0 0 5
SSRE 0.6 5 105 1 1 0 4 1
SSRE, S. reticulata stem and root extract.
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(Figure  3A). At the E:T ratio of 10:1, splenocytes of SSRE-
administered mice had higher NK cell activity than did those of 
mice administered JCM1134, although this difference was not 
significantly higher than the NK cell activity detected in spleno-
cytes of control mice (Figure 3B).
Regarding the NK cell activity in pulmonary cells, at the E:T 
ratio of 10:1, it increased in mice administered both SSRE and 
JCM1134 when compared with the NK cell activity in pulmonary 
cells of mice in the control group (Figure 4A). However, at the 
E:T ratio of 5:1, the NK cell activity was comparable across all 
treatment groups (Figure 4B).
effect of Salacia extract upon 
administration of an antibiotic cocktail
The body weight of mice drastically decreased after antibiotic 
administration. As a result, most tissues, including spleen, were 
substantially small and thus, collecting a sufficient number of 
cells from them for the analyses proved difficult. Hence, to ensure 
reliability and based on the results from Experiment 2, it was 
decided to use splenocytes and pulmonary cells only at E:T ratios 
of 25:1 and 10:1, respectively.
At the 25:1 E:T ratio, SSRE administration induced an increase in 
NK cell activity in splenocytes of antibiotic-administered mice that 
reached a level similar to that detected in splenocytes of mice not 
treated with antibiotics (Figure 5A). Likewise, at the 10:1 E:T ratio, 
NK cell activity in pulmonary cells of antibiotic-treated mice was 
increased by SSRE administration to a level similar to that detected 
in splenocytes of mice not given the antibiotic cocktail (Figure 5B).
DiscUssiOn
Salacia species were previously found to have potential immu-
nomodulatory properties for treating influenza in vitro (39, 40). 
At these premises, we also observed that administration of a bark 
FigUre 5 | natural killer cell activity in splenocytes and pulmonary 
cells of influenza-infected mice administered S. reticulata stem and 
root extract after given an antibiotic cocktail. Antibiotic administration 
drastically decreased the body weight, and hence, the size of tissues of mice 
also decreased. As a result, the number of splenocytes and pulmonary cells 
for the analyses was insufficient. Thus, splenocytes (a) and pulmonary cells 
(B) were used only at effector cell:target cell (E:T) ratios of 25:1 and 10:1, 
respectively. Antibiotics: mice given an antibiotic cocktail in drinking water 
consisting of 1 g/L of ampicillin, 500 mg/L of vancomycin, 1 g/L neomycin 
sulfate, and 1 g/L of metronidazole + 500 μL of phosphate-buffered saline 
(PBS). Antibiotic–SSRE: mice administered the antibiotic cocktail + 500 μL of 
S. reticulata stem and root extract in PBS (1.2 mg/mL of PBS). Control: mice 
with intact microbiota given 500 μL of phosphate-buffered saline (PBS). Each 
horizontal bar represents the mean value for six mice. *P < 0.05.
FigUre 4 | natural killer cell activity in pulmonary cells of influenza-
infected mice administered either L. casei JcM1134 or S. reticulata 
stem and root extract. (a) NK cell activity in pulmonary cells of mice at an 
effector cell:target cell (E:T) ratio of 10:1. (B) NK cell activity in pulmonary 
cells of mice at an E:T ratio of 5:1. Control: mice given 500 μL of phosphate-
buffered saline (PBS). JCM1134: mice administered 108 cfu of L. casei 
JCM1134 in 500 μL of PBS. SSRE: mice administered 500 μL of S. reticulata 
stem and root extract in PBS (1.2 mg/mL of PBS). Each horizontal bar 
represents the mean value for six mice. *P < 0.05.
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and root extract from S. reticulata triggered an  antiviral immune 
response in rat ileum involving Cd26 and IgG2a (30). Therefore, 
we wanted to test whether SSRE would trigger similar immune 
responses in H1N1 influenza-inoculated mice.
Excessive production of immune cells, such as neutrophils 
and lymphocytes, during influenza infection often leads to severe 
lung inflammation (41). In contrast, our results showed that upon 
SSRE administration, pulmonary inflammation of lung tissues 
markedly decreased (Figure  2B) and cough scores improved 
(Table 1) in influenza-inoculated mice. Similar effects were previ-
ously reported in influenza virus-infected mice that administered 
a compound prepared with extracts from plant roots and rice 
grains (42). It is very likely that SSRE was effective in reducing 
production of immune cells by inhibiting influenza viral replica-
tion. For example, in previous work, it was reported that Salvia 
chinenesis inhibited the binding of viral double stranded RNA 
and non-structural protein 1 (39) expressed in nuclei of H5N1 
virus-infected cells (43). Non-structural  protein 1 is essential for 
the virus replication cycle (44), blocks gene expression (45), and 
antagonizes innate immune response (46) initiated in host cells.
In the present study, we focused on NK cell activity to 
further evaluate the protective effect of SSRE against H1N1 
influenza virus-infected mice. NK cells are the first line of 
defense against influenza infection (7). However, if NK cell 
activity is not regulated, healthy cells may also be damaged 
by NK cell cytotoxicity (47). While we observed that SSRE 
administration substantially enhanced NK cell activity, his-
tological observation confirmed that there was no excessive 
infiltration of cells in lung tissues of SSRE-administered mice. 
Hence, we believe that although SSRE administration induced 
an increase in NK cell activity, it also activated regulatory 
processes that maintained the number of NK cells produced 
under control. A preliminary experiment conducted in our 
laboratory provided further evidence for this theory, as it sug-
gested that SSRE administration did not alter NK cell activity 
in splenocyte and pulmonary cells of healthy mice, that is, 
mice not infected with influenza virus (data not shown). 
In other words, this result seems to indicate an absence of 
overstimulation by SSRE of NK cell activity under healthy 
conditions. Our results also showed that at high E:T ratios, 
NK cell activity was enhanced in splenocytes and pulmonary 
cells of SSRE-administered mice, but at lower E:T ratios, 
NK cell activity was not different across treatment groups. 
During viral infections, cell-to-cell contact between NK cells 
and infected cells downregulates receptors on NK cell surface, 
such as NKG2D and NKp30, which inhibits NK cell activity 
in vivo (48). Thus, high effector/target ratios at primary infec-
tion sites are required for an effective immune protection (49), 
which is consistent with our results.
In Experiments 1 and 2, it is very probable that gut microbiota 
of mice played a role in the effects observed after administration 
of SSRE. Evidence suggests that during viral infection, gut micro-
biota helps reduce host susceptibility by exerting colonization 
resistance (50) to prevent adhesion of pathogens and maintain 
immune homeostasis. Indeed, gut microbiota has been suggested 
to upregulate the expression of NK cell surface ligands on IEC 
when microbiota imbalance and intestinal inflammation are 
detected (51). Influenza virus infection, however, can severely 
alter the composition of gut microbiota and disrupt gut homeo-
stasis. For example, previous studies showed that influenza virus 
infection increased exposure of galactose and mannose residues 
on IEC surfaces and hence overexpression of glycoreceptors, 
which increased adhesion of pathogens and caused an elevated 
production of proinflammatory cytokines (52).
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Certain LAB strains with probiotic activity also show 
antiviral properties. Moreover, LAB supplementation to 
influenza-infected models has been reported to help protect 
against influenza infections. For example, LAB preparations 
were demonstrated to modulate immune responses in influenza 
virus-infected mice (16–19), which resulted in lower virus titer 
(16) and improved clinical symptoms (20). Therefore, to estimate 
the immunomodulatory properties of SSRE, in Experiment 2, 
we tested SSRE against JCM1134, a bacterial strain previously 
used elsewhere as adjuvant to help increase in vitro NK cell activ-
ity (53). Interestingly, our results showed that NK cell activity 
induced by SSRE was similar to or greater than that induced by 
JCM1134, especially in spleen, which suggests that SSRE could be 
used as an alternative or complement to LAB supplementation to 
treat influenza infections.
Although detailed investigation of the molecular mechanisms 
of action of individual active ingredients in SSRE was beyond 
the scope of the present work, two routes can be theorized. S. 
reticulata is rich in phytochemicals with immunomodulatory 
properties, such as polyphenols salacinol, kotalanol (54, 55), 
epigallocatechin, and epicatechin (56). Thus, one route may 
have been an indirect effect by salacinol and kotalanol. Salacinol 
and kotalanol likely inhibited disaccharidases, including 
α-glucosidase, in the gut of mice (54, 55, 57), which altered the 
composition of gut microbiota, such as the ratio between firmi-
cutes and bacteroidetes (30). This shift in microbial composition 
resulted in an increased release of activated cytokines, such as 
NKT cell-induced IFN-γ in IEC (9).
An alternative route may have been a more direct effect of 
phytochemicals in SSRE, as they were likely absorbed unaltered. 
Indeed, phytochemicals, such as catechins, may have stimulated 
NK cell immune surveillance levels (58) which, upon detection 
of viral particles, inhibited further replication of influenza 
virus (59). To test this alternative route, in Experiment 3, mice 
were administered SSRE after being given a powerful antibiotic 
cocktail and inoculated with influenza virus. We confirmed by 
fecal smear assays that the antibiotic cocktail removed most gut 
microbiota, because at the start and end of SSRE/PBS adminis-
tration, only a negligible number of bacteria were found in feces 
of antibiotic-administered mice (data not shown). Moreover, 
as expected, the sole administration of antibiotics drastically 
inhibited NK activity in mice (Figure  5), the result of which 
was chosen as baseline to test the effect of SSRE administration. 
The significant reduction in NK activity detected in microbiota-
deprived mice was likely due to the microbiota composition was 
severely altered by the antibiotic administration (60), which in 
turn caused downregulation of gene expression and disruption 
of the immune response (61). Antibiotics, such as azithromycin 
(62) and neomycin (63), reportedly suppress NK cell cytotoxic-
ity and vancomycin decreases IFN-γ levels (51). Thus, the fact 
that the administration of SSRE increased NK cell activity to 
normal levels in splenocytes and pulmonary cells of microbiota-
deprived mice was somewhat unexpected (Figures 5A,B). These 
results strongly suggest that phytochemicals in SSRE, possibly 
catechins, stimulated without mediation of gut microbiota an 
increase in NK cell activity in spleen and lungs. Moreover, these 
results are in concordance with previous work reporting the 
effectivity of a mixed extract from three edible plants, namely, 
Angelica radix, Cnidium rhizome, and Paeonia radix, in helping 
restore the proliferative response, cytokine production, and NK 
cell activity in splenocytes of aged mice with impaired immune 
response (64). Further investigation of the antiviral activity 
of phytochemicals in S. reticulata is needed to determine the 
underlying molecular mechanisms of action against influenza 
infection.
In summary, in the present work, we assayed the antiviral 
properties of an extract from stems and roots of S. reticulata. 
We showed that SSRE administration markedly reduced clinical 
symptoms and immune cells infiltration in lung tissues of influenza 
virus-infected mice. In addition, SSRE administration induced 
an increase in NK cell activity in splenocytes and pulmonary 
cells of mice equal to or greater than that observed in JCM1134-
administered mice. The enhancement of NK cell activity by SSRE 
may contribute at least to some extent to the attenuation of lung 
damage observed in Experiment 1. Furthermore, when SSRE was 
given to mice deprived of gut microbiota by an antibiotic cocktail, 
NK cell activity was increased to a level similar to that observed 
in mice not given antibiotics. It can be reasonably concluded that 
at least some of the protective effects exerted by phytochemicals 
in SSRE against influenza infection were not necessarily through 
modulation of gut microbiota, but the underlying molecular 
mechanisms need to be further elucidated.
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